CanMED: NDC

Drug Name (Brand or Generic) Separate terms with OR to return results that match either term.

Major Class

Package in use from (mm/dd/yyyy):

To:

SEER*Rx Category

Clear All

9,752 Matching Results — Export these results

Click column titles once to sort ascending, and twice to sort descending.

Show Entries

NDC-11 (Package)	NDC-9 (Product)	Generic Name	Brand Name	Strength	SEER*Rx Category	Major Class	Minor Class (Ascending)	Administration Route	Package Effective Date	Status
62856-0720-05	62856-0720	Lenvatinib	Lenvima	10.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FGF, PDGFR, KIT, RET	Oral	Feb. 13, 2015	In Use
62856-0720-30	62856-0720	Lenvatinib	Lenvima	10.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FGF, PDGFR, KIT, RET	Oral	Feb. 13, 2015	In Use
62856-0714-05	62856-0714	Lenvatinib	Lenvima		Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FGF, PDGFR, KIT, RET	Oral	Feb. 13, 2015	In Use
62856-0714-30	62856-0714	Lenvatinib	Lenvima		Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FGF, PDGFR, KIT, RET	Oral	Feb. 13, 2015	In Use
62856-0718-05	62856-0718	Lenvatinib	Lenvima		Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FGF, PDGFR, KIT, RET	Oral	May 17, 2016	In Use
62856-0718-30	62856-0718	Lenvatinib	Lenvima		Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FGF, PDGFR, KIT, RET	Oral	May 13, 2016	In Use
62856-0724-05	62856-0724	Lenvatinib	Lenvima		Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FGF, PDGFR, KIT, RET	Oral	Feb. 13, 2015	In Use
62856-0724-30	62856-0724	Lenvatinib	Lenvima		Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FGF, PDGFR, KIT, RET	Oral	Feb. 13, 2015	In Use
50419-0488-58	50419-0488	Sorafenib	Nexavar	200.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FGF, PDGFR, KIT, RET, CRAF, BRAF	Oral	Dec. 20, 2005	In Use
00378-1201-78	00378-1201	Sorafenib	Sorafenib Tosylate	200.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FGF, PDGFR, KIT, RET, CRAF, BRAF	Oral	June 1, 2022	In Use
43598-0458-04	43598-0458	Sorafenib	Sorafenib	200.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FGF, PDGFR, KIT, RET, CRAF, BRAF	Oral	June 8, 2022	In Use
43598-0458-36	43598-0458	Sorafenib	Sorafenib	200.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FGF, PDGFR, KIT, RET, CRAF, BRAF	Oral	June 8, 2022	In Use
00597-0143-60	00597-0143	Nintedanib	Ofev	100.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FGFR, PDGFR, FLT3, CSF1R	Oral	Oct. 17, 2014	In Use
00069-0550-38	00069-0550	Sunitinib Malate	Sutent	12.5 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Jan. 26, 2006	In Use
00069-0770-38	00069-0770	Sunitinib Malate	Sutent	25.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Jan. 26, 2006	In Use
00069-0830-38	00069-0830	Sunitinib Malate	Sutent	37.5 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	July 12, 2014	In Use
00069-0980-38	00069-0980	Sunitinib Malate	Sutent	50.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Jan. 26, 2006	In Use
63304-0091-27	63304-0091	Sunitinib malate	Sunitinib malate	12.5 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Dec. 25, 2019	In Use
63304-0091-86	63304-0091	Sunitinib malate	Sunitinib malate	12.5 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Dec. 25, 2019	In Use
63304-0092-27	63304-0092	Sunitinib malate	Sunitinib malate	25.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Dec. 25, 2019	In Use
63304-0092-86	63304-0092	Sunitinib malate	Sunitinib malate	25.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Dec. 25, 2019	In Use
63304-0093-27	63304-0093	Sunitinib malate	Sunitinib malate	37.5 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Dec. 25, 2019	In Use
63304-0093-86	63304-0093	Sunitinib malate	Sunitinib malate	37.5 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Dec. 25, 2019	In Use
63304-0094-27	63304-0094	Sunitinib malate	Sunitinib malate	50.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Dec. 25, 2019	In Use
63304-0094-86	63304-0094	Sunitinib malate	Sunitinib malate	50.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Dec. 25, 2019	In Use
00093-8229-28	00093-8229	Sunitinib Malate	Sunitinib Malate	37.5 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Dec. 22, 2021	In Use
00093-8231-28	00093-8231	Sunitinib Malate	Sunitinib Malate	50.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Dec. 22, 2021	In Use
00093-8224-28	00093-8224	Sunitinib Malate	Sunitinib Malate	25.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Dec. 22, 2021	In Use
00093-8199-28	00093-8199	Sunitinib Malate	Sunitinib Malate	12.5 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Dec. 22, 2021	In Use
00378-6678-28	00378-6678	Sunitinib malate	Sunitinib Malate	12.5 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Jan. 4, 2022	In Use
00378-6679-28	00378-6679	sunitinib malate	Sunitinib Malate	25.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Jan. 4, 2022	In Use
00378-6680-28	00378-6680	Sunitinib malate	Sunitinib Malate	50.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Jan. 4, 2022	In Use
00378-6681-28	00378-6681	Sunitinib malate	Sunitinib Malate	37.5 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Jan. 4, 2022	In Use
16714-0679-01	16714-0679	Sunitinib malate	Sunitinib malate	50.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Feb. 18, 2022	In Use
16714-0678-01	16714-0678	Sunitinib malate	Sunitinib malate	37.5 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Feb. 18, 2022	In Use
16714-0677-01	16714-0677	Sunitinib malate	Sunitinib malate	25.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Feb. 18, 2022	In Use
16714-0676-01	16714-0676	Sunitinib malate	Sunitinib malate	12.5 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Feb. 18, 2022	In Use
43598-0045-28	43598-0045	SUNITINIB MALATE	SUNITINIB MALATE	12.5 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Nov. 30, 2022	In Use
43598-0045-63	43598-0045	SUNITINIB MALATE	SUNITINIB MALATE	12.5 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Nov. 30, 2022	In Use
43598-0046-28	43598-0046	SUNITINIB MALATE	SUNITINIB MALATE	25.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Nov. 30, 2022	In Use
43598-0046-63	43598-0046	SUNITINIB MALATE	SUNITINIB MALATE	25.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Nov. 30, 2022	In Use
43598-0047-28	43598-0047	SUNITINIB MALATE	SUNITINIB MALATE	37.5 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Nov. 30, 2022	In Use
43598-0047-63	43598-0047	SUNITINIB MALATE	SUNITINIB MALATE	37.5 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Nov. 30, 2022	In Use
43598-0048-28	43598-0048	SUNITINIB MALATE	SUNITINIB MALATE	50.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Nov. 30, 2022	In Use
43598-0048-63	43598-0048	SUNITINIB MALATE	SUNITINIB MALATE	50.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, CSF	Oral	Nov. 30, 2022	In Use
00480-5425-89	00480-5425	Sorafenib	Sorafenib	200.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, RET/PTC, CRAF, BRAF	Oral	Jan. 3, 2023	In Use
24979-0715-44	24979-0715	Sorafenib	Sorafenib	200.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, RET/PTC, CRAF, BRAF	Oral	Dec. 1, 2022	In Use
24979-0715-04	24979-0715	Sorafenib	Sorafenib	200.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, RET/PTC, CRAF, BRAF	Oral	Dec. 1, 2022	In Use
51990-0201-06	51990-0201	Sorafenib	Sorafenib	200.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, RET/PTC,CRAF, BRAF	Oral	Dec. 31, 2021	In Use
51990-0201-12	51990-0201	Sorafenib	Sorafenib	200.0 mg/1	Chemotherapy	Tyrosine Kinase Inhibitor	VEGFR, FLT, PDGFR, KIT, RET, RET/PTC,CRAF, BRAF	Oral	Dec. 31, 2021	In Use

Found 9,752 results in 16 milliseconds — Export these results

CanMED and the Oncology Toolbox

CanMED: NDC